The chronic neuroinflammation in AD is further characterized by proinflammatory biochemical processes, including the release of proinflammatory cytokines, mainly interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), and IL-6 (35). This evidence concerns the gene IL1B and Alzheimer disease.